Introduction
Atopic Dermatitis (AD) is a chronic inflammatory disorder characterized by eczematous skin lesions, itch, skin pain, sleep disturbances, and multiple atopic and non-atopic comorbidities, all of which can lead to significant morbidity [1] [2] [3] [4] . While many studies showed quality of life (QOL) impairment in clinical cohorts of AD, the patient-burden and QOL impact ACCEPTED MANUSCRIPT
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Page 4 of 25 of AD in the United States population is not well-established. Moreover, little is known about how the burden of AD compares with other chronic health disorders. We hypothesized that AD is associated with impaired QOL overall in the US population, and even greater QOL impairment than other common chronic diseases.
AD is a heterogeneous disorder with variable intensity and extent of lesions, frequency and intensity of symptoms. All of these may variably impact the burden of disease. Yet, the complex relationship between these different aspects of AD severity and QOL impact has not been examined in depth. We hypothesized that patients with severe skin lesions, high frequency of symptoms and severe pruritus have a greater QOL decrement compared to those with only one or none of these disease aspects being severe.
Moderate and severe AD patients have a greater likelihood of having comorbid asthma 5 , hay fever 5 , food allergies 5 , mental health disturbances 6 and possibly cardio-metabolic comorbidities 3 . Each of these comorbidities may negatively impact QOL. We hypothesized that AD, in particular moderate and severe AD, is associated with poor QOL independent of these comorbidities. In the present study, data were analyzed from a US-population based survey to explore the complex relationship between different constructs of AD severity, comorbidities and overall QOL.
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Methods

Data Source
Data were obtained from the Atopic Dermatitis in America survey whose population was sampled from the long-standing GfK Knowledge Panel. The GfK Knowledge panel is the largest and oldest probability-based web panel in the US and contains between 40,000 to 50,000 adult panel members at any given time. The GfK web panel was initially constructed from a national address-based sample of households in the US who are recruited to join in and receive small incentives for participating in web surveys on a regular basis. This approach uses a single sampling frame via the Delivery Sequence File of the US Postal Service to provide a statistically valid representation of the US population as well as many difficult-to-survey populations. The
GfK web panel also provides internet access to households without existing internet access. This web-based panel has been previously used in other large, epidemiological studies and has been shown to be representative of the US population [7] [8] [9] . The survey questionnaire and protocol were approved by the ICF Institutional Review Board.
Study design
This was a cross-sectional study involving a two-stage sampling process. Stage 1 was designed to determine the prevalence of AD in US adults. In this stage, an initial cross-sectional sample of 2,137 adults from the existing GfK Knowledge web panel was invited to participate in the survey. The focus of the survey was not disclosed in the invitation to members of the web panel to avoid biasing participation based on respondent interest or disinterest in the subject. A total of 1,278 adults completed the survey (response rate=59.80%). Although this sample provided a precise estimate of the prevalence of AD among the adult population, it did not yield Figure 1 ). Using data from the US Census Bureau, sample weights were created that adjusted for age, gender, race, ethnicity, education level, census region, household income, home ownership status and metropolitan area using an iterative proportional fitting procedure. Sample weights were included in all analyses to allow for representative estimates of the US population.
Assessment of AD and comorbidities
An adaptation of the UKWP criteria was selected by the AD in America advisory committee as the screening tool for patient eligibility 10 . This included all aspects of the UKWP criteria (having an itchy skin condition during the past 12 months and 3 or more of the following:
[1] history of skin crease involvement; [2] a personal history of asthma or hay fever; [3] a history of general dry skin during the past year; [4] visible flexural eczema and/or [5] onset under the age of two), except assessment of visible flexural eczema by a clinician was not performed. The following comorbidities were self-reported: ever history of either asthma or hay fever, 1-year history of food allergy, anxiety or depression, high blood pressure, diabetes, heart disease, autoimmune disease, other chronic diseases, and current obesity (body mass index ≥30).
Self-assessments of AD severity and burden included the self-reported global AD severity question "Would you describe your atopic dermatitis or eczema as mild, moderate, or For all analyses of AD severity, scores were divided into four categories (none, clear/almostclear/mild, moderate, severe/very severe) using the respective previously reported severity strata 13, 17 .
Statistical analyses
All data analyses and statistical processes were performed using SAS version 9.4 (SAS Institute) and included representative sample weights. Baseline respondent characteristics were determined. Chi-square was used to test the association between AD severity and the impact of AD on limiting lifestyle, social interaction and activity. Kruskal-Wallis was used to test the association between combined severe vs. mild-moderate POEM, PO-SCORAD and/or PO-SCORAD-itch. The most and second-most burdensome self-reported symptoms and signs of AD were examined. These are referred to as symptoms throughout the manuscript owing to their self-report.
To determine the relationship of AD with overall health rating and life satisfaction, logistic regression models were constructed with health rating and life satisfaction (excellent/very good/good/fair/poor) as the independent variables and AD (yes/no) as the dependent variable. To determine the relationship of AD severity, ordinal logistic regression models were constructed with self-reported global AD severity as the dependent variable, and health rating and life satisfaction as the independent variables. Linear regression models were also constructed with POEM or PO-SCORAD (continuous) as the dependent variable, and health rating and life satisfaction as the independent variables. To determine the relationship of AD and The multiple dependent tests performed in this study increase the risk of falsely rejecting the null hypothesis. Therefore, P-values were corrected for the false discovery rate 18 ; corrected P-values are presented. A 2-sided corrected P-value <0.05 was taken to indicate statistical significance for all estimates.
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Results
Respondent characteristics
Overall, the prevalence (95% CI) of AD was 7.3% (5.9-8.8%). Six hundred and two subjects met AD criteria and were included in the final cohort. Subjects were 53.6% female and 71.9% Caucasian/white, with a mean ± std. dev. age of 52.0 ± 16.3 years. Of those reporting global AD severity, 289 (wtd prev: 53.1%) reported having mild, 172 (38.8%) moderate and 34 (8.1%) severe AD. The mean ± std. dev. PO-SCORAD was 27.5 ± 18.0, POEM was 7.5 ± 6.8, and DLQI was 4.9 ± 6.6.
Health rating and satisfaction with life
A higher proportion of adults with AD reported having only fair or poor overall health (25.8% vs. 15.8%) and being somewhat or very dissatisfied with life (16.7% vs. 11.4%) compared to those without AD (Table 1) . In bivariable and multivariable logistic regression models, AD was associated with significantly poorer health rating and satisfaction with life.
More severe AD was associated with even stronger effects on health rating and life satisfaction. In particular, 35.0% and 31.6% of patients with self-reported severe AD reported only fair or poor health, and being somewhat or very dissatisfied with life (eTable 2 were all significantly associated with poor health in multivariable models controlling for sociodemographics. In addition, global AD severity, POEM and PO-SCORAD were all associated 
SF-12 mental and physical health and DLQI
The weighted mean (SD) SF-12 mental and physical health subscores for adults with AD were 45.9 (9.9) and 53.0 (2.5), respectively. These scores were compared with 9 different disorders, and healthy persons without any of these disorders ( Table 2 ). AD ranked 7 th and 8 th ,
respectively. SF-12 mental health subscores for moderate AD were lower than virtually all other disorders, and for severe AD, dramatically lower than all disorders (Tables 2 and 3 ).
Interestingly, there was little difference between physical health subscores across disorders (Table 2 ).
In bivariable linear regression and multivariable models controlling for sociodemographics, AD was associated with significantly lower SF-12 mental and physical health subscores and significantly higher DLQI (all indicating worse quality of life) (Table 3) .
However, these associations only remained significant for DLQI in multivariable models that also controlled for comorbid health conditions. In particular, asthma and other chronic disorders were the confounding variables in the multivariable models of SF-12 mental and physical health subscores.
In contrast, there were significant and stepwise decreases of SF-12 mental health subscores, and increases of DLQI scores, in all models for moderate and severe AD as judged by global AD severity, POEM, PO-SCORAD, PO-SCORAD itch and sleep. Whereas, moderate global AD severity, POEM, PO-SCORAD, PO-SCORAD itch and severe PO-SCORAD sleep were associated with lower SF-12 physical health scores in fully adjusted multivariable models.
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Since AD severity can be defined by different constructs, weighted mean SF-12 mental and physical health subscores and DLQI scores were stratified by the lesional severity and extent (PO-SCORAD), frequency of symptoms (POEM) and intensity of itch (PO-SCORAD itch) ( Figure 2) . Severe compared to mild-moderate POEM and PO-SCORAD itch alone as judged by existing interpretability bands were associated with significantly lower SF-12 mental health and higher DLQI scores (P<0.0001). Concurrent severe PO-SCORAD, POEM and/or PO-SCORADitch were associated with even lower SF-12 mental health and higher DLQI scores compared with severe scores for only one of these assessments (P<0.0001). However, there were no significant differences of mean SF-12 physical health subscores even among persons with severe PO-SCORAD, POEM and PO-SCORAD-itch (P=0.39).
Impact of AD on lifestyle, social interaction and activity
Overall, substantial proportions of adults with AD reported that AD limits their lifestyle adults with severe AD reported quite a bit or a great deal of burden in these areas.
Most burdensome symptoms of AD
The most burdensome symptoms reported by adults with AD were itch (54.4%), followed by excessive dryness or scaling (19.6%) and red or inflamed skin (7.2%) ( Figure 3D ). These were also the second most burdensome symptoms. Notably, skin pain and sleep disturbance were Together, these results indicate that AD, especially moderate-to-severe disease, is associated with a profound patient-burden among US adults.
The SF-12 is a generic, multi-dimensional QOL assessment that is not specific to skin disease, and has been studied extensively in many medical disorders. The mean SF-12 mental health scores for AD, particularly moderate and severe AD, were lower than other chronic health conditions such as heart disease, diabetes and high blood pressure. These results suggest that AD were also commonly reported. Similarly, a study of 265 adult AD patients found that numerical rating scale of itch, a measure of itch intensity, correlated better with overall AD severity than all other PRO examined 11 . However, adults with moderate and severe AD, in particular, were more likely to report that other symptoms were most burdensome. Taken together, itch is both the most common and burdensome symptom across all severities of adult AD, though additional signs, symptoms and sequela of scratching become more prominent in severe AD.
The strengths of this study include being large-scaled and population-based with a diverse sample and sample weights that allow for generalization of results to the US population, use of multiple and well-validated assessments of AD severity, and controlling for multiple confounding variables in multivariable models. We used an adaptation of the extensively validated UKWP criteria 10 to establish the diagnosis of AD. Thus, we believe that the casedefinition of AD is valid. POEM, PO-SCORAD, self-reported global AD severity and DLQI have all been studied in AD patients and found to have overall good face validity, construct However, the effects of past and present treatment were not examined. Future studies are warranted to examine the mediating effects of medication on QOL.
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In conclusion, AD is associated with lower overall health rating and life satisfaction, impaired QOL related to mental health and skin-related QOL in the US population. AD was associated with worse QOL than a number of other common chronic illnesses, including heart disease, diabetes and high blood pressure. Moderate and severe AD were particularly associated with dramatically lower QOL than all other chronic disorders examined. These data support the heavy burden that moderate and severe AD place on patients. We recommend that clinicians incorporate QOL assessments in clinical practice to determine disease-burden, identify patients requiring step-up treatment of their skin disease and potentially screen for patients with mental health disturbances. Binary logistic regression models were created with each comorbid health condition as the binary dependent variable. The independent variable was having atopic dermatitis as defined by the UK Working Party criteria. Crude adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated. Multivariable model-1 included age (continuous), sex (male/female), race/ethnicity (white/other), level of education (less than high school/high school or greater), household size and poverty income ratio (continuous). Multivariable model-2 included all covariates from model-1 and history of asthma, hay fever, food allergy, high blood pressure, diabetes, heart disease, depression/anxiety and other chronic conditions (yes/no) and body mass index (continuous). A C C E P T E D M A N U S C R I P T Bold-face P-values indicate statistical significance. Linear regression models were created with short form-12 mental or physical health subscores or Dermatology Life Quality Index (DLQI) as the dependent variables. The independent variable was having atopic dermatitis as defined by modified UK Working Party criteria or atopic dermatitis severity using self-reported global atopic dermatitis severity, POEM, PO-SCORAD, PO-SCORAD itch and PO-SCORAD sleep subscores. Crude beta and 95% confidence intervals (CI) were estimated. Multivariable model-1 included age (continuous), sex (male/female), race/ethnicity (white/other), level of education (less than high school/high school or greater), household size and poverty income ratio (continuous). Multivariable model-2 included all covariates from model-1 and history of asthma, hay fever, food allergy, high blood pressure, diabetes, heart disease, depression/anxiety and other chronic conditions (yes/no) and body mass index (continuous).
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